Brainjo Secures €2 Million Seed Funding to Advance VR-Based ADHD Therapy
Brainjo, a Regensburg-based startup, has announced a successful seed funding round, raising €2 million. This funding effort was led by High-Tech Gründerfonds (HTGF) and included participation from Andreas Weinhut and Better Ventures. The company is focused on developing innovative virtual reality (VR) therapies combined with brain-computer interfaces to treat Attention Deficit Hyperactivity Disorder (ADHD).
Pioneering VR-Based ADHD Treatment
Founded by Christian Gnerlich, Philipp Speierl, and Markus Wensauer, Brainjo aims to create prescribable digital therapeutics (DiGA/DTx) for ADHD. The company leverages the potential of VR technology in conjunction with brain-computer interfaces to offer new treatment avenues for children with ADHD. Support from major players like Meta and the German Federal Ministry underscores the promising potential of Brainjo's approach in the digital health landscape.
Investment Details
The seed funding round, led by HTGF, marks a significant step for Brainjo as it seeks to expand its therapeutic offerings. Andreas Weinhut and Better Ventures also contributed to this round, signaling strong investor confidence in the startup's vision and capabilities.
Planned Use of Funds
The newly acquired funds are expected to accelerate the development of Brainjo's VR-based ADHD therapy. The company plans to use the investment to enhance its product portfolio and potentially expand its market reach, focusing on making its therapy widely available as a prescribable treatment option.
Leadership Insights
Christian Gnerlich, CEO and Co-Founder, along with Philipp Speierl and Markus Wensauer, leads the company with a clear focus on innovation in digital therapeutics. Gnerlich expressed optimism about the funding's potential to propel Brainjo's growth and enhance its product offerings.
"This investment will allow us to further develop our VR therapy solutions and reach more children who can benefit from our innovative approach," said Gnerlich.
Conclusion
With this recent funding, Brainjo is well-positioned to make significant strides in the field of digital therapeutics for ADHD. The combination of VR technology and brain-computer interfaces represents a novel approach in the treatment landscape, offering new hope for effective management of ADHD symptoms in children.